EDITAS MEDICINE INC.

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

04 سبتمبر 2024 08:45:12 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

03 سبتمبر 2024 09:51:17 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

28 أغسطس 2024 10:27:42 بحسب NetDania Notify

Editas Medicine to Participate in Upcoming Investor Conferences

28 أغسطس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

14 أغسطس 2024 09:49:50 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

12 أغسطس 2024 08:46:03 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

09 أغسطس 2024 09:12:14 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

07 أغسطس 2024 10:59:49 بحسب NetDania Notify

Editas Medicine Announces Second Quarter 2024 Results and Business Updates

07 أغسطس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

05 أغسطس 2024 08:45:15 بحسب NetDania Notify

Editas Medicine Announces Second Quarter 2024 Results Conference Call and Corporate Update

31 يوليو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

02 يوليو 2024 08:45:34 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

01 يوليو 2024 13:01:29 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

28 يونيو 2024 08:47:12 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

27 يونيو 2024 08:45:34 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

26 يونيو 2024 09:52:15 بحسب NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

17 يونيو 2024 09:19:53 بحسب NetDania Notify

Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual Congress

14 يونيو 2024 02:01:00 بحسب Nasdaq GlobeNewswire

Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual Congress

14 يونيو 2024 02:00:00 بحسب Nasdaq GlobeNewswire

Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June

14 مايو 2024 09:00:00 بحسب Nasdaq GlobeNewswire